- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources2
- Resource Type
-
0001000001000000
- More
- Availability
-
11
- Author / Contributor
- Filter by Author / Creator
-
-
Basu, Sumanta (1)
-
Broll, Steven (1)
-
Hooker, Giles (1)
-
Lee, Myung Hee (1)
-
Soloviev, Matvey (1)
-
Tan, Sarah (1)
-
Wells, Martin (1)
-
Wells, Martin T (1)
-
#Tyler Phillips, Kenneth E. (0)
-
#Willis, Ciara (0)
-
& Abreu-Ramos, E. D. (0)
-
& Abramson, C. I. (0)
-
& Abreu-Ramos, E. D. (0)
-
& Adams, S.G. (0)
-
& Ahmed, K. (0)
-
& Ahmed, Khadija. (0)
-
& Aina, D.K. Jr. (0)
-
& Akcil-Okan, O. (0)
-
& Akuom, D. (0)
-
& Aleven, V. (0)
-
- Filter by Editor
-
-
Martelli, Pier Luigi (1)
-
null (1)
-
& Spizer, S. M. (0)
-
& . Spizer, S. (0)
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Bosch, N. (0)
-
& Brennan K. (0)
-
& Brennan, K. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Drown, S. (0)
-
& Ferretti, F. (0)
-
& Higgins, A. (0)
-
& J. Peters (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& S. Spitzer (0)
-
& Sahin. I. (0)
-
& Spitzer, S. (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Martelli, Pier Luigi (Ed.)Abstract MotivationThere is a growing interest in longitudinal omics data paired with some longitudinal clinical outcome. Given a large set of continuous omics variables and some continuous clinical outcome, each measured for a few subjects at only a few time points, we seek to identify those variables that co-vary over time with the outcome. To motivate this problem we study a dataset with hundreds of urinary metabolites along with Tuberculosis mycobacterial load as our clinical outcome, with the objective of identifying potential biomarkers for disease progression. For such data clinicians usually apply simple linear mixed effects models which often lack power given the low number of replicates and time points. We propose a penalized regression approach on the first differences of the data that extends the lasso + Laplacian method [Li and Li (Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008;24:1175–82.)] to a longitudinal group lasso + Laplacian approach. Our method, PROLONG, leverages the first differences of the data to increase power by pairing the consecutive time points. The Laplacian penalty incorporates the dependence structure of the variables, and the group lasso penalty induces sparsity while grouping together all contemporaneous and lag terms for each omic variable in the model. ResultsWith an automated selection of model hyper-parameters, PROLONG correctly selects target metabolites with high specificity and sensitivity across a wide range of scenarios. PROLONG selects a set of metabolites from the real data that includes interesting targets identified during EDA. Availability and implementationAn R package implementing described methods called “prolong” is available at https://github.com/stevebroll/prolong. Code snapshot available at 10.5281/zenodo.14804245.more » « lessFree, publicly-accessible full text available March 29, 2026
-
Tan, Sarah; Soloviev, Matvey; Hooker, Giles; Wells, Martin (, Foundations of data science)null (Ed.)Ensembles of decision trees perform well on many problems, but are not interpretable. In contrast to existing approaches in interpretability that focus on explaining relationships between features and predictions, we propose an alternative approach to interpret tree ensemble classifiers by surfacing representative points for each class -- prototypes. We introduce a new distance for Gradient Boosted Tree models, and propose new, adaptive prototype selection methods with theoretical guarantees, with the flexibility to choose a different number of prototypes in each class. We demonstrate our methods on random forests and gradient boosted trees, showing that the prototypes can perform as well as or even better than the original tree ensemble when used as a nearest-prototype classifier. In a user study, humans were better at predicting the output of a tree ensemble classifier when using prototypes than when using Shapley values, a popular feature attribution method. Hence, prototypes present a viable alternative to feature-based explanations for tree ensembles.more » « less
An official website of the United States government
